[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Optimizerx Corp (OPRX)

Optimizerx Corp (OPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 120,847
  • Shares Outstanding, K 18,765
  • Annual Sales, $ 109,430 K
  • Annual Income, $ 5,130 K
  • EBIT $ 16 M
  • EBITDA $ 22 M
  • 60-Month Beta 1.19
  • Price/Sales 1.14
  • Price/Cash Flow 6.74
  • Price/Book 0.96

Options Overview Details

View History
  • Implied Volatility 112.26% (-5.62%)
  • Historical Volatility 56.50%
  • IV Percentile 77%
  • IV Rank 41.80%
  • IV High 186.53% on 03/06/26
  • IV Low 58.91% on 05/30/25
  • Expected Move (DTE 5) 1.23 (19.14%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 237
  • Volume Avg (30-Day) 243
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 4,605
  • Open Int (30-Day) 4,264
  • Expected Range 5.21 to 7.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.09
  • Number of Estimates 3
  • High Estimate $-0.04
  • Low Estimate $-0.15
  • Prior Year $0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.77 +11.61%
on 04/13/26
8.26 -22.03%
on 04/21/26
-0.06 (-0.92%)
since 04/08/26
3-Month
5.54 +16.25%
on 03/06/26
10.90 -40.92%
on 02/09/26
-4.45 (-40.86%)
since 02/06/26
52-Week
5.54 +16.25%
on 03/06/26
22.25 -71.06%
on 10/27/25
-3.47 (-35.02%)
since 05/08/25

Most Recent Stories

More News
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

WALTHAM, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...

OPRX : 6.44 (-2.87%)
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET

WALTHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare solutions helping life sciences companies reach and engage healthcare...

OPRX : 6.44 (-2.87%)
Myomo Appoints William J Febbo to its Board of Directors

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...

MYO : 0.8276 (-5.05%)
OPRX : 6.44 (-2.87%)
OptimizeRx Appoints Mary Varghese Presti to Board of Directors

WALTHAM, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare solutions helping life sciences companies reach and engage healthcare...

OPRX : 6.44 (-2.87%)
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

-   Q4 revenue of $32.2 million -   Q4 gross profit increased 9% year-over-year to $24.1 million -   Q4 net income and adjusted EBITDA hit records at $5.0 million and $12.0 million, respectively...

OPRX : 6.44 (-2.87%)
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

-   Q4 revenue of $32.2 million -   Q4 gross profit increased 9% year-over-year to $24.1 million -   Q4 net income and adjusted EBITDA hit records at $5.0 million and $12.0 million, respectively...

OPRX : 6.44 (-2.87%)
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET

WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...

OPRX : 6.44 (-2.87%)
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing

WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life science companies reach and...

OPRX : 6.44 (-2.87%)
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network

WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...

OPRX : 6.44 (-2.87%)
AI Spending in Healthcare and Wellness Triples as Personalized Wellness Platforms Scale

Issued on behalf of Aleen Inc. VANCOUVER – Baystreet.ca News Commentary – Healthcare's artificial intelligence transformation is accelerating at unprecedented speed, with AI spending hitting...

OPRX : 6.44 (-2.87%)
CTSH : 51.68 (-0.50%)
CERT : 6.31 (unch)
OABI : 1.6600 (+12.93%)
ALEN-U.CN : 0.9800 (unch)

Business Summary

OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers...

See More

Key Turning Points

3rd Resistance Point 6.84
2nd Resistance Point 6.71
1st Resistance Point 6.57
Last Price 6.44
1st Support Level 6.30
2nd Support Level 6.17
3rd Support Level 6.03

See More

52-Week High 22.25
Fibonacci 61.8% 15.87
Fibonacci 50% 13.90
Fibonacci 38.2% 11.92
Last Price 6.44
52-Week Low 5.54

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.